Can disease management reduce health care costs by improving quality?

Disease management (DM) promises to achieve cost savings by improving the quality of care for chronic diseases. During the past decade the Permanente Medical Group in Northern California has implemented extensive DM programs. Examining quality indicators, utilization, and costs for 1996-2002 for adults with four conditions, we find evidence of substantial quality improvement but not cost savings. The causal pathway--from improved care to reduced morbidity to cost savings--has not produced sufficient savings to offset the rising costs of improved care. We conclude that the rationale for DM programs, like the rationale for any medical treatments, should rest on their effectiveness and value.

[1]  Brian T. Austin,et al.  Improving chronic illness care: translating evidence into action. , 2001, Health affairs.

[2]  Janet Tomcavage,et al.  Does diabetes disease management save money and improve outcomes? A report of simultaneous short-term savings and quality improvement associated with a health maintenance organization-sponsored disease management program among patients fulfilling health employer data and information set criteria. , 2002, Diabetes care.

[3]  E. Holve,et al.  Health benefits in 2003: premiums reach thirteen-year high as employers adopt new forms of cost sharing. , 2003, Health affairs.

[4]  J. Newhouse.  Medical-care expenditure: a cross-national survey. , 1977, The Journal of human resources.

[5]  Nick York,et al.  Hospital bed utilisation in the NHS, Kaiser Permanente, and the US Medicare programme: analysis of routine data , 2003, BMJ : British Medical Journal.

[6]  Thomas Bodenheimer,et al.  Improving primary care for patients with chronic illness: the chronic care model, Part 2. , 2002, JAMA.

[7]  C. Bocchino,et al.  Disease management practices of health plans. , 2002, The American journal of managed care.

[8]  B. Wheatley.  Medicaid disease management: seeking to reduce spending by promoting health. , 2001, State Coverage Initiatives issue brief : a national initiative of the Robert Wood Johnson Foundation.

[9]  B. Wheatley.  Disease management: findings from leading state programs. , 2002, State Coverage Initiatives issue brief : a national initiative of the Robert Wood Johnson Foundation.

[10]  H. Kerstjens,et al.  Costs and effects of inhaled corticosteroids and bronchodilators in asthma and chronic obstructive pulmonary disease. , 1995, American journal of respiratory and critical care medicine.

[11]  M. Johannesson,et al.  Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group. , 1997, The New England journal of medicine.